公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2012 | A cocktail regimen of intravesical mitomycin-C, doxorubicin, and cisplatin (MDP) for non-muscle-invasive bladder cancer | CHUNG-HSIN CHEN ; Yang H.-J.; CHIA-TUNG SHUN ; CHAO-YUAN HUANG ; KUO-HOW HUANG ; HONG-JENG YU ; YEONG-SHIAU PU | Urologic Oncology: Seminars and Original Investigations | 31 | 31 | |
2001 | Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma | CHIH-HUNG HSU ; Chen J.; Wu C.-Y.; ANN-LII CHENG ; YEONG-SHIAU PU | Anticancer Research | 27 | 24 | |
1996 | Combined cytotoxic effects of tamoxifen and chemotherapeutic agents on bladder cancer cells: A potential use in intravesical chemotherapy | YEONG-SHIAU PU ; Hsieh T.-S.; ANN-LII CHENG ; Tseng N.-F.; Su I.-J.; CHANG-YAO HSIEH ; Lai M.-K.; Tsai T.-C. | British Journal of Urology | 22 | 21 | |
2016 | Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma | Yang S.-M.; CHAO-YUAN HUANG ; Shiue H.-S.; YEONG-SHIAU PU ; Hsieh Y.-H.; Chen W.-J.; Lin Y.-C.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 10 | 10 | |
2018 | Comparative analysis between radical cystectomy and trimodality therapy for clinical Stage II Bladder Cancer: Experience from a tertiary referral center | JIAN-HUA HONG ; Lin Y.-H.; YU-CHUAN LU ; YUN CHIANG ; Tai H.-C.; KUO-HOW HUANG ; CHIA-HSIEN CHENG ; YEONG-SHIAU PU | Urological Science | 2 | 0 | |
2019 | Comparative efficacy and safety of new surgical treatments for benign prostatic hyperplasia: Systematic review and network meta-analysis | SHI-WEI HUANG ; Tsai C.-Y.; CHI-SHIN TSENG ; Shih M.-C.; Yeh Y.-C.; KUO-LIONG CHIEN ; YEONG-SHIAU PU ; YU-KANG TU | The BMJ | 75 | 58 | |
2008 | Comparative genomic hybridization study of arsenic-exposed and non-arsenic-exposed urinary transitional cell carcinoma | Hsu L.-I.; Chiu A.W.; YEONG-SHIAU PU ; Wang Y.-H.; Huan S.K.; Hsiao C.-H.; Hsieh F.-I.; Chen C.-J. | Toxicology and Applied Pharmacology | 13 | 13 | |
2013 | Comparing the joint effect of arsenic exposure, cigarette smoking and risk genotypes of vascular endothelial growth factor on upper urinary tract urothelial carcinoma and bladder cancer | Wang Y.-H.; Yeh S.-D.; Wu M.-M.; Liu C.-T.; Shen C.-H.; Shen K.-H.; YEONG-SHIAU PU ; Hsu L.-I.; Chiou H.-Y.; Chen C.-J. | Journal of Hazardous Materials | 35 | 31 | |
2008 | Comparison between hand-assisted laparoscopic and retroperitoneoscopic nephroureterectomy for the management of upper urinary tract urothelial carcinoma: Analysis of an intermediate follow-up period | Chung S.-D.; SHIH-CHIEH CHUEH ; CHAO-YUAN HUANG ; Lai M.-K.; YEONG-SHIAU PU ; HONG-JENG YU ; KUO-HOW HUANG | Surgical Laparoscopy, Endoscopy and Percutaneous Techniques | 4 | 4 | |
2009 | Comparison of 6- and 12-core prostate biopsy in Taiwanese men: Impact of total prostate-specific antigen, prostate-specific antigen density and prostate volume on prostate cancer detection | CHIANG I-NI ; SHANG-JEN CHANG ; YEONG-SHIAU PU ; KUO-HOW HUANG ; HONG-JENG YU ; CHAO-YUAN HUANG | Urologia Internationalis | 8 | 7 | |
2018 | Comparison of arsenic methylation capacity and polymorphisms of arsenic methylation genes between bladder cancer and upper tract urothelial carcinoma | CHAO-YUAN HUANG ; Lin Y.-C.; Shiue H.-S.; Chen W.-J.; Su C.-T.; YEONG-SHIAU PU ; Ao P.-L.; Hsueh Y.-M. | Toxicology Letters | 24 | 22 | |
2022 | The comparison of efficacy between the connaught and tice strains of bacillus calmette-guérin in patients with non-muscle-invasive bladder cancer in Taiwan | Kuo, Chih Chun; Chiang, Bing Juin; Yu, Jung Yang; Hsieh, Yu Ting; CHUNG-HSIN CHEN ; YEONG-SHIAU PU | Urological Science | 0 | 0 | |
2014 | Comparison of genome-wide DNA methylation in urothelial carcinomas of patients with and without arsenic exposure | Yang T.-Y.; Hsu L.-I.; Chiu A.W.; YEONG-SHIAU PU ; Wang S.-H.; Liao Y.-T.; Wu M.-M.; Wang Y.-H.; Chang C.-H.; Lee T.-C.; Chen C.-J. | Environmental Research | 32 | 25 | |
2006 | Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study | CHIA-CHI LIN ; CHIH-HUNG HSU ; YEONG-SHIAU PU | Anticancer Research | 0 | 0 | |
2008 | Correlation between the urine profile of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone metabolites and N7-methylguanine in urothelial carcinoma patients | Lee H.-L.; Hsueh Y.-M.; Chung C.-J.; YEONG-SHIAU PU ; Chang L.W.; Hsieh D.P.H.; Liou S.-H.; Lin P. | Cancer Epidemiology Biomarkers and Prevention | 17 | 17 | |
2009 | Correlation between the urine profile of 4-(methylnitrosamino)-1-(3- pyridyl)-1-butanone metabolites and n7-methylguanine in urothelial carcinoma patients (Cancer Epidemiology Biomarkers and Prevention (2008) 17, (3390-3395)) | Lee H.-L.; Hsueh Y.-M.; Chung C.-J.; YEONG-SHIAU PU ; Chang L.W.; Hsientang Hsieh D.P.; Liou S.-H.; Lin P. | Cancer Epidemiology Biomarkers and Prevention | 0 | 0 | |
1995 | Correlation of expression of CD44 isoforms and E-cadherin with differentiation in human urothelial cell lines and transitional cell carcinoma | RUEY-LONG HONG ; YEONG-SHIAU PU ; Chu J.-S.; Lee W.-J.; YAO-CHANG CHEN ; Wu C.-W. | Cancer Letters | 33 | 33 | |
2018 | Corrigendum to "Polymorphisms of Arsenic (+3 Oxidation State) Methyltransferase and Arsenic Methylation Capacity Affect the Risk of Bladder Cancer" | Lin Y.-C.; Chen W.-J.; CHAO-YUAN HUANG ; Shiue H.-S.; Su C.-T.; Ao P.-L.; YEONG-SHIAU PU ; Hsueh Y.-M. | Toxicological sciences : an official journal of the Society of Toxicology | 1 | 1 | |
2018 | Corrigendum to The polymorphism XRCC1 Arg194Trp and 8-hydroxydeoxyguanosine increased susceptibility to arsenic-related renal cell carcinoma. Toxicology and Applied Pharmacology 332 (2017) 1–7 (S0041008X17303095) (10.1016/j.taap.2017.07.012)) | Hsueh Y.-M.; Lin Y.-C.; Chen W.-J.; CHAO-YUAN HUANG ; Shiue H.-S.; YEONG-SHIAU PU ; Chen C.-H.; Su C.-T. | Toxicology and Applied Pharmacology | 0 | 0 | |
2001 | Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells | YEONG-SHIAU PU ; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; Hour T.-C. | Journal of Urology | 20 | 18 | |